Molecular pathogenesis and current pathology of pulmonary hypertension.
about
Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats.VEGF Promoter Polymorphism Confers an Increased Risk of Pulmonary Arterial Hypertension in a Chinese PopulationOestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.Pulmonary Vascular Platform Models the Effects of Flow and Pressure on Endothelial Dysfunction in Associated Pulmonary Arterial Hypertension
P2860
Molecular pathogenesis and current pathology of pulmonary hypertension.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Molecular pathogenesis and current pathology of pulmonary hypertension.
@en
type
label
Molecular pathogenesis and current pathology of pulmonary hypertension.
@en
prefLabel
Molecular pathogenesis and current pathology of pulmonary hypertension.
@en
P2860
P1476
Molecular pathogenesis and current pathology of pulmonary hypertension.
@en
P2093
Vinicio A de Jesus Perez
P2860
P2888
P304
P356
10.1007/S10741-015-9519-2
P577
2015-12-22T00:00:00Z